Editors:
Focuses on the duration and safety of anabolic and antiresorptive drug therapies for osteoporosis
Examines common and serious side effects of extended drug treatment, especially bisphosphonates
Discusses diagnosis and management of osteonecrosis of the jaw and atypical femur fractures
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (23 chapters)
-
Front Matter
About this book
Providing a comprehensive review of short-and long-term adverse events of both antiresorptive and anabolic drugs, this practical guide updates the clinician on the pathophysiology of osteoporosis and the principles behind our present and future pharmaceuticals. Leading practitioners in the field examine all current literature and data regarding the duration and safety of these therapies, with recommendations for clinicians on decision-making and best practices for osteoporosis patients. An overview of the pathophysiology and epidemiology of osteoporosis and discussion of both anabolic and antiresorptive drugs is followed by fracture risk assessment and an examination of treatment failures. Next, a number of chapters are dedicated to the diagnosis, presentation and management of atypical femur fractures and osteonecrosis of the jaw (ONJ), each of which are significant patient concerns when using these osteoporosis treatments. The introduction and utilization of drug holidays is also discussed, as well as the long-term outlook for management of osteoporotic patients. Written and edited by experts in the field, The Duration and Safety of Osteoporosis Treatment is a balanced resource for researchers, practitioners and policy-makers alike for clinical decision-making and patient care.
Editors and Affiliations
-
Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center; University of California Los Angeles, David Geffen School of Medicine, Los Angeles, USA
Stuart Silverman
-
Institute of Clinical Research; Department of Medicine, Holbæk, Denmark, University of Southern Denmark, Odense Patient Data Explorative Network; Holbæk Hospital, Odense, Denmark
Bo Abrahamsen
About the editors
Stuart L. Silverman, MD, FACP, FACR
Cedars-Sinai Medical Center
Division of Rheumatology
Department of Medicine
Los Angeles, CA, USA
University of California Los Angeles
David Geffen School of Medicine
Los Angeles, CA, USA
Bo Abrahamsen, MD, PhD
University of Southern Denmark
Odense Patient Data Explorative Network
Institute of Clinical Research
Odense, Denmark
Holbæk Hospital
Department of Medicine
Holbæk, Denmark
Bibliographic Information
Book Title: The Duration and Safety of Osteoporosis Treatment
Book Subtitle: Anabolic and Antiresorptive Therapy
Editors: Stuart Silverman, Bo Abrahamsen
DOI: https://doi.org/10.1007/978-3-319-23639-1
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2016
Softcover ISBN: 978-3-319-23638-4Published: 08 January 2016
eBook ISBN: 978-3-319-23639-1Published: 29 December 2015
Edition Number: 1
Number of Pages: XVI, 338
Number of Illustrations: 62 b/w illustrations, 38 illustrations in colour
Topics: Endocrinology, Orthopedics